Health Care & Life Sciences » Pharmaceuticals | Beijing Beilu Pharmaceutical Co. Ltd.

Beijing Beilu Pharmaceutical Co. Ltd.

Beijing Beilu Pharmaceutical Co. Ltd.
Stock Exchange Shenzhen Stock Exchange
EPS
CNY0.33
Market Cap
CNY4.42 B
Shares Outstanding
399.69 M
Public Float
289.04 M

Profile

Address
7/F, Blk A, Fenglan Intl Office Bldg
Beijing Beijing 100082
China
Employees -
Website http://www.beilu.com.cn
Updated 07/08/2019
Beijing Beilu Pharmaceutical Co., Ltd. engages in the development, production, and sale of pharmaceutical product. Its products cover contrast medium product, glimepiride, and anti-anxiety product. The contrast medium product includes ferric ammonium citrate, gadopentetate, and iohexol injection.

Financials

View All

Dai Xue Wang
Chairman
Xu Wang
Vice Chairman & General Manager